TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $294.0K2011: $685.0K2012: $753.0K2013: $1.65M2014: $593.0K2015: $2.10M2016: $1.60M2017: $2.03M2018: $844.0K2019: $2.74M2020: $3.45M2022: $412.0K2023: $551.0K2024: $725.0K2025: $1.34M$1.34M
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$1.34M+84.6%
2024$725.0K+31.6%
2023$551.0K+33.7%
2022$412.0K—
2020$3.45M+26.1%
2019$2.74M+224.2%
2018$844.0K-58.4%
2017$2.03M+26.6%
2016$1.60M-23.8%
2015$2.10M+254.8%
2014$593.0K-64.0%
2013$1.65M+118.6%
2012$753.0K+9.9%
2011$685.0K+133.0%
2010$294.0K—